skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Pharmacology

(Last updated: November 1, 2012; last reviewed: November 1, 2012)

Member Financial Disclosure
Company Relationship
McNicholl, Ian
University of California, San Francisco Bristol-Myers Squibb Speaker’s Bureau
Gilead Speaker’s Bureau
ViiV Healthcare Speaker’s Bureau
Pau, Alice*
National Institutes of Health
None N/A
Peloquin, Charles
University of Florida
Abbott Research Support
Jacobus Pharmaceuticals
Research Support
Otsuka
Advisory Board
Pfizer Research Support
Tibotec Advisory Board
Pham, Paul Johns Hopkins University  Barclay Consultant
Maryland MADAP Consultant
Robertson, Sarah
Food and Drug Administration
Vertex Salary
Weidle, Paul
Centers for Disease Control and Prevention
None N/A
*Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.

Back to Top